Hosted on MSN1h
Removing Health Data From Government Websites Puts Patients at Risk, Experts Warn
Removing information from the CDC website, as well as other federal health websites, is endangering both patient care and ...
Trump officials ask CDC, FDA to use gender notice on restored websites
The Trump administration had directed health agencies to place a notice condemning “gender ideology” on health webpages that ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Trump administration gives warning about ‘gender ideology’ on some government health websites
Some of the public health websites that the US government was ordered to restore involving gender and gender identity now ...
FiercePharma2h
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
MedPage Today2h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Muffin Recall Sparks Warning to Customers
LLC is recalling its six count raisin bran muffins due to a labeling error, the U.S. Food and Drug Administration said.
Healio2h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Medscape2h
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
C&EN2h
FDA approves drug for neurofibromatosis
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade)
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect ...
Federal workers ordered to return to work may find no office space exists
President Donald Trump in January ordered federal workers back to the office full time, but some workers say they don't have a desk or an office to go back to.